Gordon Brandt, Executive VP of Science and Clinica at NASTECH PHARMACEUTICAL CO INC (NSTK), sold 675 shares at $15.67 ($11K) on 2006-12-22, disclosed to the SEC on 2006-12-22.
Open-market sale of $11k NSTK by Executive VP of Science and Clinica. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| NSTK | SELL | 2007-01-05 | $73K | — | Filing → |
| NSTK | SELL | 2006-12-07 | $81K | — | Filing → |
| NSTK | SELL | 2006-11-03 | $82K | — | Filing → |